Workflow
Five9(FIVN) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
财务数据和关键指标变化 - Q1营收同比增长13%,主要受订阅收入同比增长14%推动 [26] - 订阅收入占总收入的80%,使用收入占13%,专业服务占7% [27] - 企业收入(订阅、使用和专业服务)占LTM收入的90%,商业业务占10%且LTM基础上个位数下降 [27] - LTM美元留存率为107%,上季度为108% [28] - Q1调整后毛利率同比增加约160个基点至62.4%,调整后EBITDA利润率同比增加约360个基点至18.8% [28] - 第一季度非GAAP每股收益为0.62美元,同比增长0.14美元或29% [29] - 基于股票的薪酬同比下降12%,从4500万美元降至3900万美元,占第一季度收入的14% [29] - 运营现金流达4840万美元,占收入的17.3%,自由现金流达3490万美元,占收入的12.5%,自由现金流转化率为66% [30][31] - 2025年全年营收指引维持在11.4亿美元,第二季度营收指引中点为2750万美元 [34] - 2025年非GAAP每股收益中点提高至2.76美元,第二季度非GAAP每股收益指引中点为0.65美元 [34] 各条业务线数据和关键指标变化 - 订阅收入增长主要由新客户积压订单、安装基础预订三年来最高同比增长率和企业AI收入32%的同比增长驱动 [26] - 企业AI收入在第一季度同比增长32%,占企业订阅收入的9% [14] - 几乎所有ARR超过100万美元的新客户都继续采用AI,AI占企业新客户ACV预订的20%以上 [14] 各个市场数据和关键指标变化 - 核心CCaaS市场TAM为24亿美元,随着云迁移持续,市场机会大 [15] - 国际业务占公司业务的12%,在新客户方面面临一些阻力,但安装基础客户仍有信心 [83] 公司战略和发展方向和行业竞争 - 公司目标是通过转型举措提升长期竞争地位,在2027年调整后EBITDA基础上达到并超过40规则,自由现金流基础上接近40规则 [4] - 公司将优先投资AI和市场推广举措,以推动收入增长并利用不断扩大的TAM [4] - 公司通过裁员4%优化成本,预计2025年调整后EBITDA利润率至少提高2个百分点 [32][33] - 公司在AI领域具有领先地位,通过Genius AI套件为客户提供价值,推动订阅收入增长 [8] - 公司与Salesforce、ServiceNow、Google Cloud、IBM等合作伙伴加强合作,拓展市场机会 [7][16][17][18] 管理层对经营环境和未来前景的评论 - 宏观环境存在不确定性,公司在制定指引时采取更谨慎的立场 [33] - 尽管面临挑战,公司对长期全球机会持乐观态度,尤其是高端市场 [15] - 公司预计自由现金流生成将显著改善,有望实现净现金正向 [31] 其他重要信息 - 公司宣布4月3日全球裁员4%,主要影响美国部门,预计年化非GAAP薪酬相关费用净减少2000 - 2500万美元 [32] - 预计与裁员相关的一次性现金支出为700 - 900万美元,非现金支出为100 - 150万美元 [33] 总结问答环节所有的提问和回答 问题: 订阅收入全年趋势及Q1是否为低谷 - 公司未给出订阅增长具体指引,全年总营收指引维持在1.14亿美元不变,Q1宏观环境相对稳定,Q2不确定性增加,公司采取更谨慎立场,订阅收入趋势类似总营收 [38][39] 问题: 40规则目标中调整后EBITDA、自由现金流与营收增长的分解 - 中期假设营收增长10 - 15%(假设宏观环境稳定),EBITDA利润率在25 - 30%,预计中期毛利率达66 - 68%,主要由订阅毛利率提升和收入结构向订阅业务转移驱动,同时公司将继续控制运营费用 [41][42] 问题: 企业端销售周期延长情况 - 主要是大型企业交易销售周期延长,国际市场因地缘政治因素对美国供应商有阻力,但公司关注安装基础客户,部分交易滑至下一季度,团队仍在跟进 [49][50][51] 问题: Genius AI在当前环境下对客户决策的影响 - 不确定时期影响决策,但AI革命促使公司加快采用AI,公司在AI领域有良好势头,新客户和安装基础客户对AI解决方案的采用率高,且AI能为客户带来实际ROI [57][58][60] 问题: 转型对组织各部门的影响 - 裁员涉及大多数部门,主要在美国,但销售能力未受影响,公司将继续在市场推广和AI举措上投资,确保内部战略一致 [62] 问题: Five9 Fusion中BYOT增长的驱动因素 - Salesforce大力推动其客户采用BYOT,Five9 Fusion简化了市场推广,使各方更好理解价值主张,BYOT高端产品需要公司的语音流或转录流来驱动Einstein,从而带来更多机会 [65][66] 问题: 公司内部转型的市场推广举措内容 - 包括产品和市场推广两方面,产品上加大对AI的投资,市场推广上有销售执行和组织变革、漏斗顶部营销举措,同时注重安装基础客户的渗透,如AI蓝图计划和相关组织变革 [72][73][74] 问题: 全年指引的压力测试情况 - 年初设定指引时假设今年下半年季节性增长较去年更温和,鉴于不确定性增加,进一步调低预期,Q1超预期770万美元提供了缓冲,虽有大客户业务结束的不利因素,但AI业务增长和安装基础预订增长等积极因素可抵消,最终确定全年营收指引不变 [79][80][81] 问题: 国际公司对美国供应商的抵制风险及应对 - 国际业务占比12%,主要在新客户方面有阻力,安装基础客户仍有信心,公司作为全球公司,能就数据处理等问题与客户沟通,随着时间推移有望继续在国际市场执行,从指引来看,剩余增量收入大部分来自现有客户和已在积压订单中的新客户,可见度较高 [83][85][88] 问题: 与BT合作在关税公告后的进展 - 与BT的关系依然牢固,业务和订单获取情况良好,公司在国际市场依赖合作伙伴,将继续与BT合作执行 [93] 问题: 合作伙伴的联合销售激励情况 - 所有合作伙伴都有良好的联合销售安排,双方都有激励措施,且有专门人员合作推广联合价值主张 [97][98][99] 问题: 中期运营模型中AI收入贡献及对毛利率的影响 - 中期目标10 - 15%的营收增长包含当前AI的发展势头,若AI加速发展有进一步增长空间,AI业务毛利率较高,如收购的Inference业务毛利率在70 - 80%且有提升,AI收入占比增加将推动整体毛利率上升 [101][102] 问题: 未来营收预期及10 - 15%增长的缓冲情况 - 10 - 15%的增长预期是运营审查的结果,反映了公司对销售能力和市场推广举措的投资,近期季度增长13%,指引更谨慎,AI业务采用消费型定价将成为营收增长驱动力,公司与合作伙伴的合作将带来更多机会 [111][112][113] 问题: 转录流业务在下半年的预期 - 转录流和语音流API层在战略合作伙伴关系中变得更重要,虽目前规模较小,但有望成为增长因素,在与其他CRM供应商合作中可实现盈利 [115][116] 问题: 漏斗顶部举措内容及薪酬结构是否改变 - 公司一直在优化薪酬结构和激励计划,可能会引入新的指标或KPI,如在安装基础销售团队中针对AI销售设置激励措施 [120][121] 问题: 净留存率下滑及未来稳定性 - DBR降至107%在季度初已预期,主要受大客户业务结束和季节性下降影响,未来虽仍有不利因素,但AI业务增长和高ARR客户留存率高可抵消,预计全年会有小幅度波动 [124][125] 问题: 延长交易周期的应对举措及Five9 Fusion与Salesforce关系的发展 - 销售团队专注于在新客户业务中同时交付AI和平台,交易周期延长主要是公司更关注支出,Five9 Fusion目前主要推动BYOT机会以驱动Einstein,未来有望实现更多渠道路由和Agent Force相关功能 [129] 问题: AI收入包含的产品及对毛利率的影响 - AI收入仅包括收购Inference后推出的AI产品,如AI自助服务、AI代理、代理辅助等,不包括简单自动化和WEM功能,中期来看,AI业务成本下降且公司软件开发高效,预计对毛利率是推动而非阻碍 [136][137][138]
Grid Dynamics(GDYN) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
Grid Dynamics (GDYN) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good afternoon, everyone. Welcome to Grid Dynamics First Quarter twenty twenty five Earnings Conference Call. I'm Cary Savas, Director of Branding and Communications. Joining us on the call today are CEO, Leonard Lifshitz CFO, Anil Dorado CTO, Eugene Steinberg and SVP, Americas, Vasily Sizov. Following the prepared remarks, we will open the call to your questions. Please note that today's conference call is being recorded. Statemen ...
Amgen(AMGN) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
Amgen (AMGN) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 My name is Julianne, and I will be your conference facilitator today for the Amgen Q1 FY twenty twenty five Earnings Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question and answer session at the conclusion of the last speaker's prepared remarks. In order to ensure that everyone has a chance to participate, we would like to request that you limit yourself to asking one question durin ...
Asure Software(ASUR) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
Asure Software (ASUR) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good afternoon, and welcome to Asure's First Quarter twenty twenty five Earnings Conference Call. Joining us for today's call are Chairman and CEO, Pat Gopel Chief Financial Officer, John Pence and Vice President of Investor Relations, Patrick McKillop. Following their prepared remarks, there will be a question and answer session for the analysts and investors. I would now like to turn the call over to Patrick McKillop for introdu ...
El Pollo Loco(LOCO) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
El Pollo Loco (LOCO) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good day ladies and gentlemen and thank you for standing by. Welcome to the El Polo Loco First Quarter twenty twenty five Earnings Conference Call. At this time, all participants have been placed in a listen only mode and the lines will be open for your questions following the presentation. Please note that this conference is being recorded today, 05/01/2025. And now I would like to turn the conference over to Ira Phills, the compa ...
Frontier (ULCC) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
Frontier Group Holdings (ULCC) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the Frontier Group Holdings Q1 twenty twenty one Earnings Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I wo ...
Cohu(COHU) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
Cohu (COHU) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good day, and thank you for standing by. Welcome to Cohu's First Quarter twenty twenty five Financial Results Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you'll need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. Please be advised that today's conferenc ...
Adaptive Biotechnologies(ADPT) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
Adaptive Biotechnologies (ADPT) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in listen only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. ...
Kura Oncology(KURA) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
Kura Oncology (KURA) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Please standby. Your program is about to begin. If you need assistance during your conference today, please press 0. Good day everyone and welcome to today's First Quarter twenty twenty five CURA Oncology Financial Results Conference Call. At this time, all participants are in a listen only mode. Later, you will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any t ...
Travere Therapeutics(TVTX) - 2025 Q1 - Earnings Call Transcript
2025-05-02 04:30
Travere Therapeutics (TVTX) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good afternoon, and welcome to the Traveer Therapeutics First Quarter twenty twenty five Financial Results Conference Call. Today's call is being recorded. At this time, I would like to turn the conference call over to Victoria Prescott, Manager of Investor Relations. Please go ahead, Victoria. Speaker1 Thank you, Chloe. Good afternoon, and welcome to Traveo Therapeutics first quarter twenty twenty five financial results and ...